ALTTO Test of Dual HER2 Blockade Finds Single Agent – Trastuzumab – Remains...
Journalists: Broadcast soundbites with Dr. Perez are available in the downloads. CHICAGO — In the largest clinical trial testing the effectiveness of one versus two drugs to treat HER2-positive breast...
View ArticleClik here to view.
Trastuzumab (Herceptin) Continues to Show Life-Altering Benefit
Years After Treatment for HER2-Positive Early Stage Breast Cancer Trastuzumab Shows Life-Altering Benefit JACKSONVILLE, Fla. — After following breast cancer patients for an average of eight-plus...
View ArticleClik here to view.
The Race is On …
The 8th annual 26.2 with Donna Finish Breast Cancer Marathon is underway this weekend in Jacksonville, Fla. It's the only marathon in the country where all race proceeds and donated funds go to breast...
View ArticleMayo receives federal grant to test innovative triple-negative breast cancer...
JACKSONVILLE, Fla. — Researchers on Mayo Clinic’s Florida campus have been awarded a $13.3 million, five-year federal grant to test a vaccine designed to prevent the recurrence of triple-negative...
View ArticleClik here to view.
Dr. Perez shares perspective on new ‘Stand Up To Cancer’ Health Equity...
Dr. Edith Perez, a Mayo Clinic oncologist and chair of the Stand Up To Cancer committee for health equity in cancer clinical trials today announced a new Stand Up To Cancer Health Equity Initiative...
View ArticleClik here to view.
Exploring health care disparities in minority populations
In recognition of National Minority Health Month, a number of Mayo Clinic experts participated in a virtual Mayo Clinic media briefing to discuss health care disparities that affect racial and ethnic...
View ArticleClik here to view.
Racing to find a cure for breast cancer
Every February, runners from around the country descend on Mayo Clinic’s Florida campus to participate in the 26.2 with Donna — The National Marathon to Finish Breast Cancer. Named in honor of...
View Article
